Article Topic
PSM Statement on Florida’s Submission of Irresponsible Drug Importation Concept Document
WASHINGTON (August 26, 2019) – Shabbir Imber Safdar, Executive Director of The Partnership for Safe Medicines, released the following statement in response to Florida’s submission of a drug importation concept to the U.S. Department of Health and Human Services (HHS): “Florida’s Canadian Prescription Drug Importation Concept Paper [PDF] recently submitted to HHS demonstrates that Florida…
[...]UK House of Commons: No Deal Brexit Exposes U.K. to Both Counterfeit Medication and Medication Shortages
In a report published by the House of Commons, experts in the field of prescription medication described a dire situation for medicine safety in the United Kingdom (UK) if a “no-deal” departure from the European Union (EU) happens. The report noted, “Witnesses told us that, without provisions with the EU to continue to exchange data, the UK would be shut out of critical EU data exchanges on pharmacovigilance, falsified medicines and clinical trials.”
[...]Do You Know What A Pill Press Is?
Do you know what a pill press is? Drug counterfeiters can acquire a pill press and a counterfeit pill mold to churn out counterfeit medications for less than $500. Unfortunately, “garage manufacturers” are not careful about manufacturing controls, and their products often contain fatal doses of fentanyl or other drugs. Since 2015, bootleg prescription drugs…
[...]Senator McSally Meets with Experts on the Counterfeit Drug Trade
The Arizona Republic has reported that Executive Director Shabbir Safdar, along with Maricopa County Sheriff Paul Penzone, Pinal County Sheriff Mark Lamb, U.S. Drug Enforcement Administration special agent in charge Doug Coleman, and Phoenix-area pharmacist Randle House and met with U.S. Senator Martha McSally in Arizona on August 8th to seek her assistance and support for efforts to protect the U.S. prescription drug supply from counterfeit medication
[...]Canadian Physician Warns that American Drug Importation is Bad for Canada
This editorial by Dr. Charles S. Shaver was published in The Hamilton Spectator on August 11, 2019. Dr. Shaver i a practicing physician in Ottawa. He is a graduate of Princeton University and Johns Hopkins School of Medicine. Dr. Shaver is also past chair of the section on general internal medicine of the Ontario Medical Association.
[...]Canadians Concerned About US Prescription Drug Importation Proposals
John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.
[...]Economist Warns that Federal Drug Importation is Folly
This editorial by Wayne Winegarden, Ph.D. appeared in Forbes on August 7, 2019. Dr. Winegarden is the Managing Editor for EconoSTATS and a senior Fellow in Business and Economics at the Pacific Research Institute.
[...]Policy Expert: “Even if Canada were a willing participant, the U.S. can’t ensure the safety of these drugs.”
In this
San Diego is in the Midst of a Deadly Counterfeit Pill Crisis, with 50 Confirmed Deaths Thus Far
U.S. Attorney Robert Brewer has issued a public safety warning concerning deadly counterfeit oxycodone pills in San Diego County. NBC San Diego reports, “The U.S. Attorney’s Office said border seizures, prosecutions and overdoses in San Diego County are on pace to reach all-time highs by the end of 2019. The Medical Examiner’s Office reports 50 confirmed fentanyl-related fatal overdoses so far this year, and says 28 more suspected cases are waiting to be confirmed.”
[...]Importation Won’t Save Money, warn Citizens Against Government Waste
In this July 31, 2019 blog post on the Citizens Against Government Waste (CAGW) website, CAGW Director of Health and Science Policy Elizabeth Wright questions the questions the effectiveness and safety of government importation schemes.
[...]